Clearly, mouse models of Ras and Braf-induced cancers coupled with DUSP6 gene knockout and a more rigorous assessment of DUSP6/MKP-3 levels in larger cohorts of human tumours will be instrumental in clarifying the possible role of DUSP6/MKP-3 as a tumour suppressor. The gene discussed is BRAF; the disease is neoplasm.